Study for Novel Coronavirus Pneumonia (NCP)
Sponsor
Wuhan Union Hospital, China (Other)
Overall Status
Unknown status
CT.gov ID
NCT04283396
Collaborator
(none)
2,000
1
5.3
380.5
Study Details
Study Description
Brief Summary
To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
By retrospectively analyzing the clinical epidemiological characteristics of the novel coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth analyzing the disease development process and outcome trends of NCP patients to develop practical and effective clinical diagnosis and treatment schemes and provide guarantee for the rapid control of the epidemic.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
2000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP)
Actual Study Start Date
:
Feb 21, 2020
Anticipated Primary Completion Date
:
May 30, 2020
Anticipated Study Completion Date
:
Jul 30, 2020
Outcome Measures
Primary Outcome Measures
- recovery [up to 24 weeks]
Number of patients recover from novel coronavirus pneumonia
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to "Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial Version 5)";
Exclusion Criteria:
- Physician judged the patient was not suitable for this clinical trial.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Union hospital | Wuhan | Hubei | China | 430000 |
Sponsors and Collaborators
- Wuhan Union Hospital, China
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Yang Jin,
Professor,
Wuhan Union Hospital, China
ClinicalTrials.gov Identifier:
NCT04283396
Other Study ID Numbers:
- NCP01
First Posted:
Feb 25, 2020
Last Update Posted:
Mar 17, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms: